MyFinsight
Home
Blog
About
Contact
something is missing
$5,497M
Manufacturing cost of sales
-$2,812M
(-211.23%↓ Y/Y)
Research and development
-$1,925M
(-229.54%↓ Y/Y)
Sales and marketing
-$1,100M
(-203.19%↓ Y/Y)
Interest expense, net
-$722M
(-199.86%↓ Y/Y)
General and
administrative
-$709M
(-214.17%↓ Y/Y)
Profit share and
royalties in cost of sales
-$537M
(-222.05%↓ Y/Y)
Net income
$1,819M
(5.14%↑ Y/Y)
Depreciation, amortization
and other
$1,116M
(-19.54%↓ Y/Y)
Net proceeds from
issuance of debt
$3,964M
Canceled cashflow
$11,483M
Accounts payable
$571M
(14.89%↑ Y/Y)
Trade receivables,
net
-$413M
(-131.57%↓ Y/Y)
Loss (gain) on equity
securities
-$143M
(-111.04%↓ Y/Y)
Stock-based compensation
expense
$75M
(-11.76%↓ Y/Y)
Long-term tax liabilities
$71M
(1.43%↑ Y/Y)
Accrued income taxes,
net
$71M
(-31.73%↓ Y/Y)
Inventories
-$18M
(93.75%↑ Y/Y)
Other assets
-$8M
(-103.98%↓ Y/Y)
Net cash provided by
operating activities
$2,189M
(57.37%↑ Y/Y)
Net cash provided by
(used in) financing...
$1,436M
(134.96%↑ Y/Y)
Canceled cashflow
$2,116M
Canceled cashflow
$2,528M
Total revenues
-$10,118M
(-224.16%↓ Y/Y)
Other segment items
$1,016M
(277.31%↑ Y/Y)
Provision for income taxes
$265M
(9.05%↑ Y/Y)
Interest income
-$84M
(-166.67%↓ Y/Y)
Increase (decrease) in
cash and cash...
$2,909M
(191.97%↑ Y/Y)
Canceled cashflow
$716M
Accrued liabilities
-$959M
(-9.73%↓ Y/Y)
Accrued sales
incentives and allowance
-$839M
(-272.63%↓ Y/Y)
Deferred income taxes
-$176M
(29.60%↑ Y/Y)
Other liabilities
-$75M
(3.85%↑ Y/Y)
Other items, net
$67M
(34.00%↑ Y/Y)
Dividends paid
$1,358M
(6.18%↑ Y/Y)
Repayment of debt
$833M
(-66.68%↓ Y/Y)
Extinguishment of debt
$233M
(-22.59%↓ Y/Y)
Other
-$104M
(-285.19%↓ Y/Y)
Net cash used in
investing activities
-$716M
(-60.18%↓ Y/Y)
Purchases of property,
plant and equipment
$712M
(73.24%↑ Y/Y)
Other
$4M
(-88.89%↓ Y/Y)
Back
Back
Cash Flow
amgen-blue-svg
AMGEN INC (AMGN)
amgen-blue-svg
AMGEN INC (AMGN)
source: myfinsight.com